Fair Richard A. 4
4 · BELLICUM PHARMACEUTICALS, INC · Filed Mar 19, 2020
Insider Transaction Report
Form 4
Fair Richard A.
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2020-03-17$4.00/sh+5,000$19,999→ 5,000 total(indirect: By Trust)
Holdings
- 6,813
Common Stock
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.97 to $4.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- [F2]Includes 157 shares acquired by the reporting person under the Issuer's 2014 Employee Stock Purchase Plan.